Evidence map›Paper›PMID 36132873›Full record

ReviewNanoscale advances2021

Nanoparticles and bioorthogonal chemistry joining forces for improved biomedical applications.

Javier Idiago-López, Eduardo Moreno-Antolín, Jesús M de la Fuente, Raluca M Fratila

Abstract readReview
In one paragraph

Review in Nanoscale advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. [Molecules (Basel, Switzerland) · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. GLUT5: structure, functions, diseases and potential applications.Acta biochimica et biophysica Sinica · 2023
    Review
  9. Perspectives on SRS Imaging of Nanoparticles.Accounts of materials research · 2023
    Article
  10. Bioorthogonal Click of Colloidal Gold Nanoparticles to Antibodies In vivo.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  11. Article
  12. Clickable Biomaterials for Modulating Neuroinflammation.International journal of molecular sciences · 2022
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Javier Idiago-LópezInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza Zaragoza 50009 Spain rfratila@unizar.es javidlo@unizar.es edmoreno@unizar.es jmfuente@unizar.es.ORCID https://orcid.org/0000-0002-3373-9341
Eduardo Moreno-AntolínInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza Zaragoza 50009 Spain rfratila@unizar.es javidlo@unizar.es edmoreno@unizar.es jmfuente@unizar.es.ORCID https://orcid.org/0000-0002-8223-3267
Jesús M de la FuenteInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza Zaragoza 50009 Spain rfratila@unizar.es javidlo@unizar.es edmoreno@unizar.es jmfuente@unizar.es.ORCID https://orcid.org/0000-0003-1081-8482
Raluca M FratilaInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza Zaragoza 50009 Spain rfratila@unizar.es javidlo@unizar.es edmoreno@unizar.es jmfuente@unizar.es.ORCID https://orcid.org/0000-0001-5559-8757

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioorthogonal chemistry comprises chemical reactions that can take place inside complex biological environments, providing outstanding tools for the investigation and elucidation of biological processes. Its use in combination with nanotechnology can lead to further developments in diverse areas of biomedicine, such as molecular bioimaging, targeted delivery,

Identifiers

PMID36132873
PMCPMC9419263

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.